A new gene therapy track to fight cancer
September 18, 2018
A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the
Scientific activities
Research institutions
The CARPEM program focuses on cross-disciplinary research leading to the development of personalized medicine.
The research teams associated with the present CARPEM project are working in the most prestigious Parisian research centers under the supervision of the Paris Descartes University:
- Cordeliers Research Centre (CRC) : 15, rue de l’Ecole de Médecine 75006 Paris
- Cochin Institute : 22, rue Méchain, 75014 Paris
- Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS) : Hôtel-Dieu, Galerie A2, first floor, 1, place du Parvis Notre-Dame, 75004 Paris
- Imagine Institute (Necker) : 24, boulevard de Montparnasse, 75015 PARIS
- PARCC – Paris, Cardiovascular Research Center : 6, rue Leblanc, 75015 PARIS
Team 1 : Personalized Medicine, Pharmacogenomics and Therapeutic Optimization (MEPPOT)
Centre Universitaire des Saints-Pères
Pr Pierre Laurent-Puig
- Laboratory : Personalized Medicine, Pharmacogenomics and Therapeutic Optimization
- Website : http://www.crc.jussieu.fr/pierre_laurent_puig.html
- Affiliations : Université PARIS DESCARTES UMRS-1138
- Address : 45 Rue des Saints-Pères 75006 Paris
- Contact : pierre.laurent-puig@parisdescartes.fr
Last publication :
Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.
There are conflicting results concerning the prognostic value of the CpG island methylator phenotype (CIMP) in patients with nonmetastatic colon cancer. We studied this phenotype in stage III colon cancer characterized for mismatch repair (MMR), RAS, and BRAF status, and treated with adjuvant FOLFOX-based regimen…
Read more
Team 2 : Functional genomics of solid tumors
Centre de recherche des Cordeliers
Pr Jessica Zucman-Rossi
- Laboratory : Functional genomics of solid tumors
- Website : http://www.crc.jussieu.fr/jessica_zucman_rossi.html ; www.zucmanlab.com
- Affiliations : Inserm U1162, CEPH, UMRS-1138
- Address : 27 rue Juliette Dodu 75010 Paris
- Contact : jessica.zucman-rossi@inserm.fr
Last publication :
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
Few single nucleotide polymorphisms (SNPs) have been reproducibly associated with hepatocellular carcinoma (HCC). Our aim was to test the association between nine SNPs and HCC occurrence. SNPs in genes linked to HCC (DEPDC5, GRIK1, KIF1B, STAT4, MICA, DLC1, DDX18) or to liver damage…
Read more
Team 3 : Genetics of pheochromocytomas and paragangliomas (PHEO and PGL)
PARCC (Paris Centre de recherche Cardiovasculaire)
Pr Anne-Paule Gimenez-Roqueplo
- Laboratory : Laboratoire d’éthique médicale et de médecine légale,
- Website : http://parcc.inserm.fr/fr/research-teams/team/pheochromocytomas-and-paragangliomas-from-genetics-to-molecular-targeted-therapies/
- Affiliations : Université PARIS DESCARTES UMRS-970
- Address : 56 Rue Leblanc 75015 Paris
- Contact : anne-paule.gimenez-roqueplo@inserm.fr
Last publication :
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors. Whereas most PPGLs are benign, up to 20% may become metastatic with SDHB- and FH-mutated tumors showing the higher risk. We aimed at determining the contribution of immortalization mechanisms to metastatic progression.
Read more
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors. Whereas most PPGLs are benign, up to 20% may become metastatic with SDHB- and FH-mutated tumors showing the higher risk. We aimed at determining the contribution of immortalization mechanisms to metastatic progression.
Read more
Team 4 : Immunotherapy and antiangiogenic therapy in oncology
PARCC (Paris Centre de recherche Cardiovasculaire)
Pr Eric Tartour
- Laboratory : Immunothérapie et traitement anti-angiogénique en cancérologie,
- Website : http://parcc.inserm.fr/research-teams/team/immunotherapy-and-anti-angiogenic-therapy-in-oncology/
- Affiliations : Université PARIS DESCARTES UMRS-970
- Address : 56 Rue Leblanc 75015 Paris
- Contact : eric.tartour@aphp.fr
Last publication :
HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population.
HPV-related and HPV-unrelated oropharyngeal squamous cell carcinomas are two distinct entities according to the Union for International Cancer Control, with a better prognosis conferred to HPV-related oropharyngeal squamous cell carcinomas. However, variable clinical outcomes are observed among patients with p16 positive…
Read more
HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population.
HPV-related and HPV-unrelated oropharyngeal squamous cell carcinomas are two distinct entities according to the Union for International Cancer Control, with a better prognosis conferred to HPV-related oropharyngeal squamous cell carcinomas. However, variable clinical outcomes are observed among patients with p16 positive…
Read more
Team 5 : Imaging of angiogenesis and its metabolic consequences
PARCC (Paris Centre de recherche Cardiovasculaire)
Pr Olivier Clément and Pr Bertrand Tavitian
- Laboratory : Imaging of angiogenesis and its metabolic consequences
- Website : http://parcc.inserm.fr/research-teams/team/tavitian/
- Affiliations : Université PARIS DESCARTES UMRS-970
- Address : 56 Rue Leblanc 75015 Paris
- Contact : olivier.clement@inserm.fr, bertrand.tavitian@inserm.fr
Last publication :
Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument.
We recently introduced a hybrid imaging instrument, PETRUS, based on a combination of positron emission tomography (PET) for molecular imaging, x-ray computed tomography (CT) for anatomical imaging, co-registration and attenuation correction, and ultrafast ultrasound imaging (UUI) for motion-correction…
Read more
Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument.
We recently introduced a hybrid imaging instrument, PETRUS, based on a combination of positron emission tomography (PET) for molecular imaging, x-ray computed tomography (CT) for anatomical imaging, co-registration and attenuation correction, and ultrafast ultrasound imaging (UUI) for motion-correction…
Read more
Team 6 : Immunologie et Cancérologie Intégratives
Centre de recherche des Cordeliers
Dr Jérôme Galon
- Laboratory : Integrative Cancer Immunology.
- Website : http://www.crc.jussieu.fr/j_r_me_gallon.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : jerome.galon@crc.jussieu.fr
Last publication :
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.
Treatment of metastatic colorectal cancer is based upon the assumption that metastases are homogeneous within a patient. We quantified immune cell types of 603 whole-slide metastases and primary colorectal tumors from 222 patients. Primary lesions, and synchronous and metachronous metastases, had…
Read more
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.
Treatment of metastatic colorectal cancer is based upon the assumption that metastases are homogeneous within a patient. We quantified immune cell types of 603 whole-slide metastases and primary colorectal tumors from 222 patients. Primary lesions, and synchronous and metachronous metastases, had…
Read more
Team 7 : Metabolism, Cancer & Immunity
Centre de recherche des Cordeliers
Pr Guido Kroemer
- Laboratory : Metebolism, Cancer & Immunity
- Website : http://www.crc.jussieu.fr/guido_kroemer2019.html ; http://www.kroemerlab.com
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine, 75006 Paris
- Contact : guido.kroemer@inserm.fr
Last publication :
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1% of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial…
Read more
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1% of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial…
Read more
Team 8 : Cancer, Immune Control and Escape
Centre de recherche des Cordeliers
Pr Isabelle Cremer
- Laboratory : Cancer, Immune Control and Escape
- Website : http://www.crc.jussieu.fr/isabelle_cremer_equipe.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : bennaci@crc.jussieu.fr
Last publication :
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.
In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive. Here, using a murine model of lung adenocarcinoma…
Read more
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.
In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive. Here, using a murine model of lung adenocarcinoma…
Read more
Team 9 : Endocrine tumors and signaling
Institut Cochin
Pr Jérôme Bertherat
- Laboratory : Endocrine tumors and signaling
- Website : https://www.institutcochin.fr/la-recherche/emd/equipe-bertherat
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact : bertherat@aphp.fr, Tel : +33 1 44 41 23 93
Last publication :
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study.
Background The combination of mitotane and platinum-etoposide chemotherapy is a front-line treatment in metastatic adrenocortical carcinoma (ACC), although this regimen shows limited efficacy. Pharmacokinetic drug-drug interaction between mitotane, a strong CYP3A4 inducer, and etoposide, which is a substrate…
Read more
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study.
Background The combination of mitotane and platinum-etoposide chemotherapy is a front-line treatment in metastatic adrenocortical carcinoma (ACC), although this regimen shows limited efficacy. Pharmacokinetic drug-drug interaction between mitotane, a strong CYP3A4 inducer, and etoposide, which is a substrate…
Read more
Team 10 : Oxidative stress, inflammation and cellular proliferation
Institut Cochin
Pr Frédéric Batteux
- Laboratory : Oxidative stress, inflammation and cellular proliferation
- Website : https://www.institutcochin.fr/la-recherche/drc/equipe-batteux
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact : batteux@aphp.fr, Tel : +33 1 58 41 21 41
Last publication :
Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
The endogenous cholinergic system plays a key role in neuronal cells, by suppressing neurite outgrowth and myelination and, in some cancer cells, favoring tumor growth. Platinum compounds are widely used as part of first line conventional cancer chemotherapy; their efficacy is however limited by peripheral neuropathy …
Read more
Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
The endogenous cholinergic system plays a key role in neuronal cells, by suppressing neurite outgrowth and myelination and, in some cancer cells, favoring tumor growth. Platinum compounds are widely used as part of first line conventional cancer chemotherapy; their efficacy is however limited by peripheral neuropathy …
Read more
Team 11 : Normal and Pathological Hematopoiesis
Institut Cochin
Pr Didier Bouscary and Pr Michaëla Fontenay
- Laboratory : Normal and Pathological Hematopoiesis
- Website : https://www.institutcochin.fr/la-recherche/drc/equipe-mayeux-bouscary
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact : bouscary@aphp.fr, michaëla.fontenay@aphp.fr
Last publication :
T-cell large granular lymphocyte leukemia transformation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.
Read more
Team 12 : Intestinal Self-Renewal and Tumorigenesis
Institut Cochin
Dr Béatrice Romagnolo and Dr Christine Perret
- Laboratory : Intestinal Self-Renewal and Tumorigenesis
- Website : https://www.institutcochin.fr/departments/drc/team-perret
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact : christine.perret@inserm.fr, beatrice.romagnolo@inserm.fr
Last publication :
LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
Hepatocellular carcinomas (HCCs) are known to be highly heterogenous. Within the extensive histopathological and molecular heterogeneity of HCC, tumors with mutations in CTNNB1, encoding β-catenin (CTNNB1-mutated HCC), constitute a very homogeneous group. We previously characterized a distinctive metabolic…
Read more
LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
Hepatocellular carcinomas (HCCs) are known to be highly heterogenous. Within the extensive histopathological and molecular heterogeneity of HCC, tumors with mutations in CTNNB1, encoding β-catenin (CTNNB1-mutated HCC), constitute a very homogeneous group. We previously characterized a distinctive metabolic…
Read more
Team 13 : Cancer and Immune Response
Institut Cochin
Dr Emmanuel Donnadieu
- Laboratory : Cancer and Immune Response
- Website : https://www.institutcochin.fr/departments/3i/team-donnadieu-randriamampita
- Affiliations : Institut Cochin, Inserm U1016, APHP
- Address : 22 Rue Mechain, 75014 Paris
- Contact : emmanuel.donnadieu@inserm.fr
Last publication :
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
In a large proportion of cancer patients, CD8 T cells are excluded from the vicinity of cancer cells. The inability of CD8 T cells to reach tumor cells is considered an important mechanism of resistance to cancer immunotherapy. We show that, in human lung squamous-cell carcinomas, exclusion of CD8 T cells from tumor islets is correlated …
Read more
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
In a large proportion of cancer patients, CD8 T cells are excluded from the vicinity of cancer cells. The inability of CD8 T cells to reach tumor cells is considered an important mechanism of resistance to cancer immunotherapy. We show that, in human lung squamous-cell carcinomas, exclusion of CD8 T cells from tumor islets is correlated …
Read more
Team 14 : Hematology and Pathology – Normal and pathological lymphoïd differenciation
Necker hospital – Imagine institute
Pr Elizabeth Macintyre and Pr Olivier Hermine
- Laboratory : Hematology and Pathology – Normal and pathological lymphoïd differenciation
- Website : https://www.institut-necker-enfants-malades.fr/index.php?menu=team&rubric=teamtabs&idfac=asnafi-macintyre
- Affiliations : Institut Necker Enfants Malades, UMRS 1151
- Address : 49 Rue de Sèvres, 75015 Paris
- Contact : elizabeth.macintyre@aphp.fr
Last publication :
Epigenetic silencing affects L-asparaginase sensitivity and predicts outcome in T-ALL.
Biological explanations for discrepancies in patients related response to chemotherapy depending on the underlying oncogenic events is a promising research area. TLX1 or TLX3 deregulated T-ALLs (TLX1/3+) share an immature cortical phenotype and similar transcriptional signatures. However, their prognostic…
Read more
Epigenetic silencing affects L-asparaginase sensitivity and predicts outcome in T-ALL.
Biological explanations for discrepancies in patients related response to chemotherapy depending on the underlying oncogenic events is a promising research area. TLX1 or TLX3 deregulated T-ALLs (TLX1/3+) share an immature cortical phenotype and similar transcriptional signatures. However, their prognostic…
Read more
Team 15 : Medical Ethics
Centre Universitaire des Saints-Pères
Pr Marie-France Mamzer
- Laboratory : Medical Ethics
- Website : https://ea4569.wordpress.com/mamzer-marie-france/
- Affiliations : Université Paris Descartes EA-4569
- Address : 45 Rue des Saints-Pères 75006 Paris
- Contact : marie-france.mamzer@parisdescartes.fr
Last publication :
How to strengthen the presence of patients in health technology assessments conducted by the health authorities.
The constant development of health technologies, combined with the increase in the cost of treatment, means that States must continually make choices about the introduction of new technologies into their healthcare system and how they are to be funded. In France, the systematic participation of patients in these processes is…
Read more
How to strengthen the presence of patients in health technology assessments conducted by the health authorities.
The constant development of health technologies, combined with the increase in the cost of treatment, means that States must continually make choices about the introduction of new technologies into their healthcare system and how they are to be funded. In France, the systematic participation of patients in these processes is…
Read more
Team 16 : Computational Epi-Genetics of cancer
Institut Cochin
Dr Valentina Boeva
- Laboratory : Computational Epi-Genetics of cancer
- Website : https://www.institutcochin.fr/la-recherche/drc/equipe-v-boeva
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact : valentina.boeva@inserm.fr
Last publication :
QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.
In cancer, clonal evolution is assessed based on information coming from single nucleotide variants and copy number alterations. Nonetheless, existing methods often fail to accurately combine information from both sources to truthfully reconstruct clonal populations in a given tumor sample or in a set of tumor samples…
Read more
Team 17 : Proliferation, Stress and Liver Physiopathology
Centre de recherche des Cordeliers
Dr Chantal Desdouets
- Laboratory : Proliferation, Stress and Liver Physiopathology
- Website : http://www.crc.jussieu.fr/chantal_desdouets.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : chantal.desdouets@inserm.fr
Last publication :
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma.
Leukocyte cell-derived chemotaxin-2 (LECT2) was originally identified as a hepatocyte-secreted chemokine-like factor and a positive target of β-catenin signaling. Here, we dissected out the mechanisms by which LECT2 modulates hepatocellular carcinoma (HCC) development using both HCC mouse models and human HCC…
Read more
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma.
Leukocyte cell-derived chemotaxin-2 (LECT2) was originally identified as a hepatocyte-secreted chemokine-like factor and a positive target of β-catenin signaling. Here, we dissected out the mechanisms by which LECT2 modulates hepatocellular carcinoma (HCC) development using both HCC mouse models and human HCC…
Read more
Team 18 : Methods of therapeutic evaluation of chronic diseases
CRESS
Pr Philippe Ravaud
- Laboratory : Methods of therapeutic evaluation of chronic diseases
- Website : https://clinicalepidemio.fr/
- Affiliations : CRESS, Centre d’épidémiologie clinique Hôpital Hôtel-Dieu, INSERM UMR1153
- Address : 1, place du parvis Notre-Dame, 75004 Paris
- Contact : sec.epidemio.htd@aphp.fr
Last publication :
Acceptable medication non-adherence: A crowdsourcing study among French physicians for commonly prescribed medications.
Achieving good medication adherence is a major challenge for patients with chronic conditions. Our study aimed to assess the Threshold for Unacceptable Risk of Non-adherence (TURN), defined as the threshold at which physicians consider the health risks incurred by patients due to medication non-adherence unacceptable…
Read more
Acceptable medication non-adherence: A crowdsourcing study among French physicians for commonly prescribed medications.
Achieving good medication adherence is a major challenge for patients with chronic conditions. Our study aimed to assess the Threshold for Unacceptable Risk of Non-adherence (TURN), defined as the threshold at which physicians consider the health risks incurred by patients due to medication non-adherence unacceptable…
Read more
Team 19 : Nutritional epidemiology
CRESS
Dr Mathilde Touvier
- Laboratory : Nutritional epidemiology
- Website : https://eren.univ-paris13.fr/index.php/en/
- Affiliations : CRESS Centre de Recherche épidémiologique et statistique Sorbonne Paris Cité, INSERM UMR1153
- Address : 74, rue Marcel Cachin, 93017 Bobigny
- Contact : r.aris@eren.smbh.univ-paris13.fr
Last publication :
Fasting and weight-loss restrictive diet practices among 2,700 cancer survivors: results from the NutriNet-Santé cohort.
Nutrition is often used by cancer survivors as a lever to take charge of their own health. However, some dietary behaviors are not currently recommended for patients without medical supervision. Our study aimed at evaluating weight-loss restrictive diets and fasting practices among cancer survivors of the…
Read more
Fasting and weight-loss restrictive diet practices among 2,700 cancer survivors: results from the NutriNet-Santé cohort.
Nutrition is often used by cancer survivors as a lever to take charge of their own health. However, some dietary behaviors are not currently recommended for patients without medical supervision. Our study aimed at evaluating weight-loss restrictive diets and fasting practices among cancer survivors of the…
Read more
Team 20 : Information Sciences to support Personalized Medicine
Centre de recherche des Cordeliers
Pr Anita Burgun
- Laboratory : Information Sciences to support Personalized Medicine
- Website : http://www.crc.jussieu.fr/anita_burgun_equipe.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : florence.bordu@crc .jussieu.fr
Last publication :
What can millions of laboratory test results tell us about the temporal aspect of data quality? Study of data spanning 17 years in a clinical data warehouse.
OBJECTIVE: To identify common temporal evolution profiles in biological data and propose a semi-automated method to these patterns in a clinical data warehouse (CDW). MATERIALS AND METHODS:We leveraged the CDW of the European Hospital Georges Pompidou and tracked the evolution of 192…
Read more
Team 21 : Metabolic Diseases, Diabetes and co-morbidities
Centre de recherche des Cordeliers
Dr Fabienne Foufelle
- Laboratory : Metabolic Diseases, Diabetes and co-morbidities
- Website : http://www.crc.jussieu.fr/fabienne_foufelle_equipe.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : valerie.resve@crc.jussieu.fr
Last publication :
Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.
Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study…
Read more
Team 22 : Oncogenic funtions of beta-catenin signaling in the liver
Centre de recherche des Cordeliers
Dr Sabine Colnot
- Laboratory : Oncogenic funtions of beta-catenin signaling in the liver
- Website : http://www.crc.jussieu.fr/sabine_colnot.html
- Affiliations : Centre de Recherche des Cordeliers, Université Paris 5, Inserm U1138
- Address : 15 Rue de l’École de Médecine 75006 Paris
- Contact : sabine.colnot@inserm.fr
Last publication :
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.
Hepatocellular carcinoma (HCC) is the most prevalent primary tumour of the liver. About a third of these tumours presents activating mutations of the β-catenin gene. The molecular pathogenesis of HCC has been elucidated, but mortality remains high, and new therapeutic approaches, including treatments based on microRNAs…
Read more
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.
Hepatocellular carcinoma (HCC) is the most prevalent primary tumour of the liver. About a third of these tumours presents activating mutations of the β-catenin gene. The molecular pathogenesis of HCC has been elucidated, but mortality remains high, and new therapeutic approaches, including treatments based on microRNAs…
Read more
Team 23 : Genomics and epigenetics of rare tumors
Institut Cochin
Dr Eric Pasmant
- Laboratory : Genomics and epigenetics of rare tumors
- Website :
- Affiliations : Institut Cochin, Inserm U1016
- Address : 22 Rue Mechain, 75014 Paris
- Contact :
Last publication :
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic Medicine.
We report the case of a patient with a BRCA2 germline mutation who developed a localized pleomorphic soft tissue sarcoma of the leg with poor prognostic features. BRCA2 germline mutations were not previously reported to be associated with pleomorphic sarcoma. BRCA2 loss-of-heterozygosity was found in the tumor, resulting…
Read more
releases
Xème Symposium Jecco
September 14, 2018
Le CARPEM soutient le Xème Symposium JeCCo “Une nouvelle approche du Cancer” qui
Presentation of CARPEM – Pr Pierre Laurent-Puig
September 14, 2018
Professor Pierre Laurent-Puig, director of CARPEM (Cancer Research for Personalized Medicine), presents the
INFORMATION
Calls for projects
2018 calls for projects are open !
Trainings
2018 trainings
Job offers
Check our job offers
Contacts
For more information, please contact
Contact us
Centre Universitaire des Saints-Pères Etage 4 – Pièce 446B 45 rue des Saints-Pères -75006 Paris
Carina Binet : Secrétaire Général du CARPEM
Tél. : 01 76 53 43 85 – carina.binet@carpem.fr
Aurore Hattabi, PhD : Coordinatrice Scientifique du CARPEM
Tél : 01 76 53 43 85 – aurore.hattabi@carpem.fr
Follow us
Menu
